The analysis, published by the Association of the British Pharmaceutical Industry (ABPI), is an encouraging sign but “is not yet enough to restore the UK’s global ranking on trials ...
In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a sharp decline (41%) in clinical trials initiated by the UK in the period 2017 to 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback